| scholarly article | Q13442814 |
| P50 | author | Sudha Seshadri | Q28516588 |
| Ramachandran S. Vasan | Q30348351 | ||
| Lisa M Sullivan | Q37382153 | ||
| Philip A Wolf | Q42561276 | ||
| Edzard Schwedhelm | Q53064392 | ||
| Vanessa Xanthakis | Q57611363 | ||
| Joseph F Polak | Q91517344 | ||
| P2093 | author name string | Renke Maas | |
| Rainer H Böger | |||
| Friedrich Schulze | |||
| Ralf Benndorf | |||
| P2860 | cites work | Prediction of Coronary Heart Disease Using Risk Factor Categories | Q22241923 |
| Disruption of methylarginine metabolism impairs vascular homeostasis | Q27643718 | ||
| Asymmetric dimethylarginine, smoking, and risk of coronary heart disease in apparently healthy men: prospective analysis from the population-based Monitoring of Trends and Determinants in Cardiovascular Disease/Kooperative Gesundheitsforschung in de | Q31102407 | ||
| Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) study | Q33254708 | ||
| Genomewide linkage analysis for internal carotid artery intimal medial thickness: evidence for linkage to chromosome 12. | Q33909610 | ||
| Asymmetrical dimethylarginine: the Uber marker? | Q34314880 | ||
| Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis | Q34604937 | ||
| Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines | Q35749970 | ||
| Pharmacotherapies and their influence on asymmetric dimethylargine (ADMA). | Q36381009 | ||
| Carotid bifurcation atherosclerosis. Quantitative correlation of plaque localization with flow velocity profiles and wall shear stress | Q36618016 | ||
| Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group | Q36900139 | ||
| Increased plasma levels of asymmetric dimethylarginine in patients with carotid stenosis: no evidence for the role of the common FABP2 A54T gene polymorphism | Q40253146 | ||
| Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study | Q40397164 | ||
| Hemodynamic shear stress and its role in atherosclerosis | Q40786692 | ||
| Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia | Q42538581 | ||
| Asymmetric dimethylarginine independently predicts fatal and nonfatal myocardial infarction and stroke in women: 24-year follow-up of the population study of women in Gothenburg | Q43594273 | ||
| Serum asymmetric dimethylarginine negatively correlates with intima-media thickness in early-onset atherosclerosis | Q43608029 | ||
| Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. | Q43850038 | ||
| Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease. | Q43862989 | ||
| Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality. | Q44294178 | ||
| Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase | Q44477052 | ||
| Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans | Q44684870 | ||
| Patterns of atherosclerosis: effect of risk factors on recurrence and survival-analysis of 11,890 cases with more than 25-year follow-up | Q44737552 | ||
| Rates and determinants of site-specific progression of carotid artery intima-media thickness: the carotid atherosclerosis progression study | Q44970486 | ||
| Segment-specific effects of cardiovascular risk factors on carotid artery intima-medial thickness in women at midlife. | Q45009065 | ||
| Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis | Q45207667 | ||
| Dimethylarginine dimethylaminohydrolase promotes endothelial repair after vascular injury | Q46170586 | ||
| Endogenous nitric oxide synthase inhibitors, arterial hemodynamics, and subclinical vascular disease: the PREVENCION Study | Q46318694 | ||
| Plasma level of asymmetric dimethylarginine (ADMA) as a predictor of carotid intima-media thickness progression: six-year prospective study using carotid ultrasonography | Q46419778 | ||
| Liquid chromatography-tandem mass spectrometry method for the analysis of asymmetric dimethylarginine in human plasma | Q46564686 | ||
| Asymmetric dimethylarginine (ADMA) as a risk marker for stroke and TIA in a Swedish population | Q46627515 | ||
| Spontaneous myocardial infarction in mice lacking all nitric oxide synthase isoforms | Q46643862 | ||
| Plasma asymmetric dimethylarginine (ADMA) concentration is independently associated with carotid intima-media thickness and plasma soluble vascular cell adhesion molecule-1 (sVCAM-1) concentration in patients with mild-to-moderate renal failure | Q46749527 | ||
| Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure | Q46861533 | ||
| Thickening of the carotid wall. A marker for atherosclerosis in the elderly? Cardiovascular Health Study Collaborative Research Group. | Q51040637 | ||
| Plasma levels of asymmetric dimethylarginine (ADMA) are related to intima-media thickness of the carotid artery: an epidemiological study. | Q51498722 | ||
| Traditional risk factors and subclinical disease measures as predictors of first myocardial infarction in older adults: the Cardiovascular Health Study. | Q51562630 | ||
| Asymmetric dimethyl-arginine and coronary artery calcification in young adults entering middle age: the CARDIA Study. | Q51756269 | ||
| Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health study). | Q51772805 | ||
| Different vasculoprotective roles of NO synthase isoforms in vascular lesion formation in mice. | Q52541512 | ||
| An investigation of coronary heart disease in families. The Framingham offspring study | Q59461737 | ||
| Relations of intimal-medial thickness among sites within the carotid artery as evaluated by B-mode ultrasound. ARIC Investigators. Atherosclerosis Risk in Communities | Q60692534 | ||
| Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. The CHS Collaborative Research Group | Q67591473 | ||
| Evidence for the pathophysiological role of endogenous methylarginines in regulation of endothelial NO production and vascular function | Q79326094 | ||
| High-throughput liquid chromatographic-tandem mass spectrometric determination of arginine and dimethylated arginine derivatives in human and mouse plasma | Q79459969 | ||
| Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2 | Q80547912 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2715-2719 | |
| P577 | publication date | 2009-06-04 | |
| P1433 | published in | Stroke Journal | Q7624282 |
| P1476 | title | Association of the endogenous nitric oxide synthase inhibitor ADMA with carotid artery intimal media thickness in the Framingham Heart Study offspring cohort | |
| P478 | volume | 40 |
| Q90162945 | Arginine Derivatives in Cerebrovascular Diseases: Mechanisms and Clinical Implications |
| Q39535124 | Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study |
| Q26864318 | Asymmetric dimethyarginine as marker and mediator in ischemic stroke |
| Q46516924 | Asymmetric dimethylarginine and symmetric dimethylarginine prospectively relates to carotid wall thickening in black men: the SABPA study. |
| Q37365823 | Differential associations of angiographic extent and severity of coronary artery disease with asymmetric dimethylarginine but not insulin resistance in non-diabetic men with stable angina: a cross-sectional study. |
| Q33509022 | Dimethylarginine dimethylaminohydrolase-1 transgenic mice are not protected from ischemic stroke |
| Q35670550 | L-Arginine and SDMA Serum Concentrations Are Associated with Subclinical Atherosclerosis in the Study of Health in Pomerania (SHIP) |
| Q37887771 | Nitric oxide: a guardian for vascular grafts? |
| Q58294630 | Plasma asymmetric dimethylarginine (ADMA) levels and atherosclerotic disease in ankylosing spondylitis: a cross-sectional study |
| Q36836196 | Residual Cardiovascular Risk in Individuals on Blood Pressure-Lowering Treatment |
| Q49634201 | Residual cardiovascular risk in individuals on lipid-lowering treatment: quantifying absolute and relative risk in the community. |
| Q42986982 | Role of asymmetric dimethylarginine in the progression of carotid atherosclerosis in renal transplant patients. |
Search more.